// <auto-generated/>
// Contents of: hl7.fhir.r4b.core version: 4.3.0
// Minimum TypeScript Version: 3.7
// FHIR ValueSet: http://hl7.org/fhir/ValueSet/research-study-phase|4.3.0
/**
 * Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.
 */
export const ResearchStudyPhaseCodes = {
    /**
     * early-phase-1: Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
     */
    EarlyPhase1: "early-phase-1",
    /**
     * n-a: Trials without phases (for example, studies of devices or behavioral interventions).
     */
    NA: "n-a",
    /**
     * phase-1: Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
     */
    Phase1: "phase-1",
    /**
     * phase-1-phase-2: Trials that are a combination of phases 1 and 2.
     */
    Phase1Phase2: "phase-1-phase-2",
    /**
     * phase-2: Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
     */
    Phase2: "phase-2",
    /**
     * phase-2-phase-3: Trials that are a combination of phases 2 and 3.
     */
    Phase2Phase3: "phase-2-phase-3",
    /**
     * phase-3: Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
     */
    Phase3: "phase-3",
    /**
     * phase-4: Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
     */
    Phase4: "phase-4",
};
//# sourceMappingURL=data:application/json;base64,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